Thank you for your interest in Milestone Pharmaceuticals. While we encourage you to explore opportunities with our company, we urge you to be cautious and wary of recruitment scams in which fraudsters pose as representatives of Milestone Pharma. All current openings are available to view on our Careers page. https://milestonepharmaceuticals.applytojob.com/ Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing the investigational new drug etripamil for the treatment of cardiovascular indications. Etripamil is a novel, potent and short-acting calcium channel blocker designed by Milestone and being developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of PSVT as they occur. Milestone is actively recruiting patients for a Phase 3 clinical trial of etripamil for the treatment of PSVT. Milestone plans to initiate a Phase 2 clinical trial in atrial fibrillation, another rapid heart rate condition, and expects to subsequently initiate an additional Phase 2 clinical trial in angina to establish proof-of-concept for the broader use of etripamil.
View Top Employees from Milestone Pharmaceuticals, Inc.Website | http://www.milestonepharma.com |
Ticker | MIST |
Revenue | $7 million |
Funding | $287.5 million |
Employees | 59 (57 on RocketReach) |
Founded | 2007 |
Address | 1111 Dr. Frederik-Philips, Montreal, Quebec H4M 2X6, CA |
Phone | (514) 336-0444 |
Technologies |
JavaScript,
HTML,
PHP
+44 more
(view full list)
|
Industry | Pharmaceuticals, Biotechnology Research, Biotechnology, Healthcare, Science and Engineering, Drug Discovery, Health Care, Therapeutics |
Web Rank | 3 Million |
Keywords | Milestone Pharmaceuticals, Etripamil, Milestone Pharmaceuticals News, Milestone Pharma, Milestone Pharmaceuticals Inc |
Competitors | Corbus Pharmaceuticals, CrystalGenomics, Inc., Diffusion Pharmaceuticals, Resverlogix Corp., Vidac Pharma |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Milestone Pharmaceuticals, Inc. employee's phone or email?
The Milestone Pharmaceuticals, Inc. annual revenue was $7 million in 2024.
Amit Hasija is the Chief Financial Officer and Executive Vice President of Corporate Development of Milestone Pharmaceuticals, Inc..
57 people are employed at Milestone Pharmaceuticals, Inc..
Milestone Pharmaceuticals, Inc. is based in Montreal, Quebec.
The NAICS codes for Milestone Pharmaceuticals, Inc. are [3254, 32541, 325, 32].
The SIC codes for Milestone Pharmaceuticals, Inc. are [283, 28].